Based on the above analysis, we found that OLFM4, IGF2BP3, CLDN1 and MMP1 were the top 4 upregulated genes in common upregulated DEGs, which implied that they could be the candidate target for diagnostic application of GC treatment. This evidence concerns the gene CLDN1 and gastric cancer.